Novozymes' Nedwin joins Dyadic International

June 1, 2006

Glenn Nedwin, cofounder and president of Novozymes Inc., joined Los Angeles-based biotechnology company Dyadic International in late March. As Dyadic's chief scientific officer, Nedwin will direct scientific and development activities, and oversee the planned expansion of the company's R&D efforts. As president of Dyadic's biosciences business, Nedwin will also be responsible for strategic business development, partnering, alliances and collaborative research relationships.

At Novozymes, Nedwin was responsible for all scientific, financial and administrative activities. He was also a member of the company's global R&D management team and its biosolutions strategy group

Advertisement

Advertisement

Upcoming Events

Sign up for our e-newsletter!

Advertisement

Advertisement